воскресенье, 10 января 2016 г.

GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas

GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas


's stock had its "neutral" rating restated by analysts at BNP Paribas in a report issued on Friday, MarketBeat Ratings reports. They presently have a GBX 1,400 target price on the stock.



from Biotech News